Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Notes Payables (2019 - 2025)

Hypha Labs' Notes Payables history spans 8 years, with the latest figure at $1.2 million for Q2 2025.

  • For Q2 2025, Notes Payables rose 12.06% year-over-year to $1.2 million; the TTM value through Jun 2025 reached $1.2 million, up 12.06%, while the annual FY2024 figure was $1.1 million, 90.84% up from the prior year.
  • Notes Payables reached $1.2 million in Q2 2025 per FUNI's latest filing, up from $1.1 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2021 to a low of $56705.0 in Q2 2021.
  • Average Notes Payables over 5 years is $754205.4, with a median of $665000.0 recorded in 2022.
  • Peak YoY movement for Notes Payables: surged 2212.2% in 2021, then crashed 37.88% in 2022.
  • A 5-year view of Notes Payables shows it stood at $1.3 million in 2021, then plummeted by 37.88% to $791444.0 in 2022, then fell by 24.7% to $595965.0 in 2023, then soared by 80.92% to $1.1 million in 2024, then increased by 12.06% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for FUNI's Notes Payables are $1.2 million (Q2 2025), $1.1 million (Q1 2025), and $1.1 million (Q4 2024).